Raymond James Financial Services Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $973K | Buy |
|
|||||
|
2024
Q2 | $1.22M | Sell |
|
|||||
|
2024
Q1 | $1.18M | Buy |
|
|||||
|
2023
Q4 | $865K | Sell |
|
|||||
|
2023
Q3 | $1.21M | Sell |
|
|||||
|
2023
Q2 | $1.19M | Buy |
|
|||||
|
2023
Q1 | $1.3M | Sell |
|
|||||
|
2022
Q4 | $2.03M | Buy |
|
|||||
|
2022
Q3 | $1.29M | Sell |
|
|||||
|
2022
Q2 | $948K | Buy |
|
|||||
|
2022
Q1 | $768K | Sell |
|
|||||
|
2021
Q4 | $936K | Sell |
|
|||||
|
2021
Q3 | $2.08M | Sell |
|
|||||
|
2021
Q2 | $2.42M | Buy |
|
|||||
|
2021
Q1 | $2.28M | Buy |
|
|||||
|
2020
Q4 | $2.1M | Buy |
|
|||||
|
2020
Q3 | $1.69M | Buy |
|
|||||
|
2020
Q2 | $1.79M | Sell |
|
|||||
|
2020
Q1 | $1.17M | Sell |
|
|||||
|
2019
Q4 | $1.76M | Sell |
|
|||||
|
2019
Q3 | $1.16M | Sell |
|
|||||
|
2019
Q2 | $2.4M | Sell |
|
|||||
|
2019
Q1 | $2.04M | Buy |
|
|||||
|
2018
Q4 | $1.36M | Buy |
|
|||||
|
2018
Q3 | $1.88M | Sell |
|
|||||
|
2018
Q2 | $1.62M | Buy |
|
|||||
|
2018
Q1 | $898K | Sell |
|
|||||
|
2017
Q4 | $1.04M | Sell |
|
|||||
|
2017
Q3 | $1.25M | Buy |
|
|||||
|
2017
Q2 | $704K | Buy |
|
|||||
|
2017
Q1 | $333K | Buy |
|
|||||
|
2016
Q4 | $221K | Sell |
|
|||||
|
2016
Q3 | $673K | Buy |
|